201 related articles for article (PubMed ID: 17699757)
21. TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK.
Plaisance I; Morandi C; Murigande C; Brink M
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E241-50. PubMed ID: 17971516
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
[TBL] [Abstract][Full Text] [Related]
23. Methods for studying signal-dependent regulation of translation factor activity.
Wang X; Proud CG
Methods Enzymol; 2007; 431():113-42. PubMed ID: 17923233
[TBL] [Abstract][Full Text] [Related]
24. Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.
Noske A; Lindenberg JL; Darb-Esfahani S; Weichert W; Buckendahl AC; Röske A; Sehouli J; Dietel M; Denkert C
Oncol Rep; 2008 Dec; 20(6):1409-17. PubMed ID: 19020722
[TBL] [Abstract][Full Text] [Related]
25. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
26. PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.
Yu L; Shang ZF; Wang J; Wang H; Huang F; Zhang Z; Wang Y; Zhou J; Li S
Oncotarget; 2015 Aug; 6(24):20356-69. PubMed ID: 26011939
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis.
Petegnief V; Font-Nieves M; Martín ME; Salinas M; Planas AM
Biochem J; 2008 May; 411(3):667-77. PubMed ID: 18215131
[TBL] [Abstract][Full Text] [Related]
28. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
29. eIF-4E expression and its role in malignancies and metastases.
De Benedetti A; Graff JR
Oncogene; 2004 Apr; 23(18):3189-99. PubMed ID: 15094768
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
Han B; Tong J; Zhu MJ; Ma C; Du M
Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
[TBL] [Abstract][Full Text] [Related]
31. ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stress.
Yamaguchi S; Ishihara H; Yamada T; Tamura A; Usui M; Tominaga R; Munakata Y; Satake C; Katagiri H; Tashiro F; Aburatani H; Tsukiyama-Kohara K; Miyazaki J; Sonenberg N; Oka Y
Cell Metab; 2008 Mar; 7(3):269-76. PubMed ID: 18316032
[TBL] [Abstract][Full Text] [Related]
32. Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells.
Roforth MM; Tan C
Anticancer Drugs; 2008 Aug; 19(7):681-8. PubMed ID: 18594209
[TBL] [Abstract][Full Text] [Related]
33. Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice.
Chang SH; Kim JE; Lee JH; Minai-Tehrani A; Han K; Chae C; Cho YH; Yun JH; Park K; Kim YS; Cho MH
Cancer Gene Ther; 2013 Jun; 20(6):331-5. PubMed ID: 23640516
[TBL] [Abstract][Full Text] [Related]
34. 4E-BPs at the crossroads of oncogenic MAPK and AKT signaling.
Topisirovic I; Sonenberg N
Pigment Cell Melanoma Res; 2010 Oct; 23(5):585-6. PubMed ID: 20704686
[No Abstract] [Full Text] [Related]
35. Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
O'Reilly KE; Warycha M; Davies MA; Rodrik V; Zhou XK; Yee H; Polsky D; Pavlick AC; Rosen N; Bhardwaj N; Mills G; Osman I
Clin Cancer Res; 2009 Apr; 15(8):2872-8. PubMed ID: 19336517
[TBL] [Abstract][Full Text] [Related]
36. Binding preference of eIF4E for 4E-binding protein isoform and function of eIF4E N-terminal flexible region for interaction, studied by SPR analysis.
Abiko F; Tomoo K; Mizuno A; Morino S; Imataka H; Ishida T
Biochem Biophys Res Commun; 2007 Apr; 355(3):667-72. PubMed ID: 17316564
[TBL] [Abstract][Full Text] [Related]
37. Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.
Chen YT; Tsai HP; Wu CC; Wang JY; Chai CY
Pathol Res Pract; 2017 May; 213(5):490-495. PubMed ID: 28242042
[TBL] [Abstract][Full Text] [Related]
38. The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.
Ramon Y Cajal S; De Mattos-Arruda L; Sonenberg N; Cortes J; Peg V
Clin Transl Oncol; 2014 Nov; 16(11):937-41. PubMed ID: 25060567
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.
Roh MS; Lee JH; Kang KW; Nam HY; Jung SB; Kim K; Lee EH; Park MI; Kim MS; Lee HW
Virchows Arch; 2015 Dec; 467(6):667-673. PubMed ID: 26445970
[TBL] [Abstract][Full Text] [Related]
40. 4E-BP1 as an oncotarget.
She QB
Aging (Albany NY); 2015 Aug; 7(8):517-8. PubMed ID: 26298157
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
